Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (12) | Back to Search
PHARMACOKINETICS OF BILIARY EXCRETED ANGIOTENSIN CONVERTING ENZYME INHIBITOR, TEMOCAPRIL, IN DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 3B AND ABOVE
- In: Poster Session
- At: Düsseldorf (Germany) (2015)
- Type: Poster
- By: YASUDA, Gen (Yokohama City University Centre Hospital, Nephrology and Hypertension, Yokohama, Japan)
- Co-author(s): Gen Yasuda
- Abstract:
In diabetic patients with chronic kidney disease (CKD) angiotensin converting enzyme inhibitors (ACEI) are the first option to reduce blood pressure. However, ACEI impair renal function in the presence of ischemic nephropathy. Temocapril, one of biliary excreted ACEI, is expected to be less accumulated. However, the pharmacokinetics during the
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023